WHO caused delay in availability of Mpox vaccines in Congo
New Indian ExpressThere are no vaccines for mpox available in the Democratic Republic of Congo, the epicenter of a global health emergency declared last week, even though the country first asked for the shots two years ago and the manufacturers say they have supplies, The New York Times reported. Three years after the last worldwide mpox outbreak, the WHO still has neither officially approved the vaccines — although the United States and Europe have — nor has it issued an emergency use license that would speed access, The New York Times report noted. One of these two approvals is necessary for UNICEF and Gavi, the organization that helps facilitate immunizations in developing nations, to buy and distribute mpox vaccines in low-income countries like Congo, the report noted. But the organization is painfully risk-averse, concerned with a need to protect its trustworthiness and ill-prepared to act swiftly in emergencies, Blair Hanewall, a global health consultant who managed the WHO approvals portfolio as a deputy director of the Bill & Melinda Gates Foundation, a key funder, for more than a decade, has been quoted as saying by The New York Times.